Morgan Stanley
MS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.43 | -0.87 | 0.65 | 0.75 |
| FCF Yield | -6.18% | 4.98% | -13.36% | 5.49% |
| EV / EBITDA | 62.18 | 92.76 | 81.28 | 73.85 |
| Quality | ||||
| ROIC | 0.77% | 0.48% | 0.75% | 0.68% |
| Gross Margin | 58.43% | 54.71% | 58.69% | 57.46% |
| Cash Conversion Ratio | -1.23 | 3.31 | -5.49 | 3.17 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.04% | 11.93% | 15.06% | 18.19% |
| Free Cash Flow Growth | -239.43% | 144.82% | -326.07% | 159.88% |
| Safety | ||||
| Net Debt / EBITDA | 35.90 | 55.30 | 52.44 | 43.47 |
| Interest Coverage | 0.46 | 0.37 | 0.49 | 0.45 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,245.11 | -1,205.43 | -1,277.52 | -1,134.01 |